In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 727.8 | 757.9 | 815.4 | 820.9 | 775.9 | 812.2 | 875.6 | 819.3 | 779.3 | 702.6 | 916.8 | 966.1 | |
| Other Income | 4.9 | 2.1 | 5.5 | 2.0 | 17.6 | 3.5 | 11.3 | 3.7 | 1.7 | 4.1 | 5.7 | 9.4 | |
| Total Income | 732.7 | 760.0 | 820.9 | 822.9 | 793.5 | 815.6 | 886.9 | 823.0 | 781.0 | 706.7 | 922.5 | 975.5 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 483.9 | 533.7 | 559.2 | 577.7 | 531.1 | 545.3 | 568.2 | 548.3 | 534.9 | 497.4 | 522.0 | 549.3 | |
| + Purchases of Stock-in-Trade | 1.6 | 1.4 | 0.8 | 0.9 | 1.2 | 1.8 | 0.9 | 1.1 | 1.5 | 2.1 | 1.1 | 1.6 | |
| + Changes in Inventories | 8.2 | -2.1 | -7.4 | -31.7 | 19.2 | 3.0 | 9.8 | -13.3 | -13.7 | -25.4 | 95.2 | 55.4 | |
| + Employee Benefit Expense | 71.3 | 72.1 | 77.5 | 78.6 | 78.0 | 78.7 | 82.6 | 81.6 | 78.3 | 81.0 | 79.6 | 82.3 | |
| + Finance Costs | 13.2 | 16.3 | 21.6 | 20.8 | 18.2 | 15.0 | 20.3 | 17.2 | 11.4 | 13.0 | 12.8 | 18.6 | |
| + Depreciation & Amortisation | 21.3 | 22.9 | 24.1 | 23.5 | 24.1 | 24.0 | 23.5 | 23.2 | 22.9 | 22.8 | 22.5 | 24.5 | |
| + Other Expenses | 151.5 | 135.8 | 145.1 | 144.1 | 143.2 | 146.5 | 149.2 | 143.9 | 152.8 | 133.0 | 160.3 | 150.4 | |
| Total Expenses | 751.0 | 780.1 | 820.8 | 813.9 | 815.0 | 814.4 | 854.5 | 801.9 | 788.0 | 723.7 | 893.4 | 882.1 | |
| EBITDA | 11.4 | 16.9 | 40.3 | 51.2 | 3.2 | 36.8 | 64.9 | 57.7 | 25.6 | 14.6 | 58.7 | 127.1 | |
| EBIT | -9.9 | -5.9 | 16.2 | 27.7 | -20.9 | 12.8 | 41.4 | 34.6 | 2.6 | -8.2 | 36.2 | 102.6 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -18.3 | -20.1 | 0.1 | 8.9 | -21.4 | 1.3 | 32.3 | 21.1 | -7.0 | -17.1 | 29.1 | 93.4 | |
| Pretax Income | -18.3 | -20.1 | 0.1 | 8.9 | -21.4 | 1.3 | 32.3 | 21.1 | -7.0 | -17.1 | 29.1 | 93.4 | |
| + Current Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Deferred Tax | -0.3 | -4.9 | 0.5 | 2.3 | -4.0 | 0.5 | 9.9 | 4.9 | -2.4 | -4.2 | 5.7 | 23.5 | |
| Tax Expense | -0.3 | -4.9 | 0.5 | 2.3 | -4.0 | 0.5 | 9.9 | 5.1 | -2.4 | -4.2 | 5.7 | 23.5 | |
| Net Income | -18.0 | -15.2 | -0.4 | 6.6 | -17.5 | 0.8 | 22.4 | 16.0 | -4.6 | -12.9 | 23.4 | 69.9 | |
| + Net Income — Continuing Ops | -18.0 | -15.2 | -0.4 | 6.6 | -17.5 | 0.8 | 22.4 | 16.0 | -4.6 | -12.9 | 23.4 | 69.9 | |
| + Other Comprehensive Income | 2.5 | -10.3 | -19.3 | 26.8 | -1.8 | 6.3 | -30.6 | 69.7 | -31.9 | -21.4 | -15.0 | 22.1 | |
| Total Comprehensive Income | -15.5 | -25.5 | -19.7 | 33.4 | -19.2 | 7.0 | -8.2 | 85.7 | -36.5 | -34.3 | 8.4 | 92.0 | |
| Per Share | |||||||||||||
| Basic EPS | -4.99 | -4.22 | 0.22 | 1.84 | -4.84 | 0.21 | 5.88 | 4.43 | -1.29 | -2.67 | 6.45 | 19.38 | |
| Diluted EPS | -4.99 | -4.22 | 0.22 | 1.84 | -4.84 | 0.21 | 5.88 | 4.43 | -1.29 | -2.67 | 6.45 | 19.38 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -30.6 | 69.7 | -31.9 | -21.4 | -15.0 | 22.1 | |
| + Items NOT to be Reclassified to P&L | 2.8 | -11.7 | -21.8 | 30.3 | 1.0 | 7.3 | -36.4 | 81.3 | -37.2 | -24.9 | -17.4 | 25.8 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | -5.8 | 11.6 | -5.3 | -3.6 | -2.4 | 3.7 | |
| + Tax on Items NOT to be Reclassified — alt tag | 0.3 | -1.4 | -2.5 | 3.5 | 2.8 | 1.1 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -4.99 | -4.22 | 0.22 | 1.84 | -4.84 | 0.21 | 5.88 | 4.43 | -1.29 | -2.67 | 6.45 | 19.38 | |
| Diluted EPS — Continuing Operations | -4.99 | -4.22 | 0.22 | 1.84 | -4.84 | 0.21 | 5.88 | 4.43 | -1.29 | -2.67 | 6.45 | 19.38 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 121.4 | — | 143.2 | — | 93.6 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 234.1 | 224.9 | 262.8 | 274.0 | 224.4 | 262.1 | 296.7 | 283.2 | 256.6 | 228.6 | 298.6 | 359.8 | |
| Gross Margin % | 32.17 | 29.67 | 32.23 | 33.37 | 28.92 | 32.27 | 33.89 | 34.57 | 32.93 | 32.53 | 32.57 | 37.25 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -18.3 | -20.1 | 0.1 | 8.9 | -21.4 | 1.3 | 32.3 | 21.1 | -7.0 | -17.1 | 29.1 | 93.4 | |
| Net Income Adj (tax-effected) | -18.0 | -15.2 | -0.4 | 6.6 | -17.5 | 0.8 | 22.4 | 16.0 | -4.6 | -12.9 | 23.4 | 69.9 | |
| EPS Adj | -4.99 | -4.22 | 0.22 | 1.84 | -4.84 | 0.21 | 5.88 | 4.43 | -1.29 | -2.67 | 6.45 | 19.38 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
| Paid Up Equity Capital | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | |